Cargando…
Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α(V)β(3)
An integrin α(V)β(3)-targeting linear RGD mimetic containing a small-molecule drug conjugate (SMDC) was synthesized by combining the antimitotic agent monomethyl auristatin E (MMAE), an enzymatically cleavable Val-Ala-PABC linker with a linear conjugable RGD mimetic. The structure proposal for the c...
Autores principales: | Paulus, Jannik, Sewald, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035832/ https://www.ncbi.nlm.nih.gov/pubmed/35480387 http://dx.doi.org/10.3389/fchem.2022.869639 |
Ejemplares similares
-
Synthesis and
Evaluation of a Monomethyl Auristatin
E—Integrin α(v)β(6) Binding Peptide–Drug
Conjugate for Tumor Targeted Drug Delivery
por: Davis, Ryan A., et al.
Publicado: (2023) -
Q2DSTD NMR deciphers epitope-mapping variability for peptide recognition of integrin αvβ6
por: Sorge, Jessica L., et al.
Publicado: (2015) -
FITC-Conjugated Cyclic RGD Peptides as Fluorescent
Probes for Staining Integrin α(v)β(3)/α(v)β(5) in Tumor Tissues
por: Zheng, Yumin, et al.
Publicado: (2014) -
Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023) -
Synthesis and Biological Evaluation of RGD and isoDGR–Monomethyl Auristatin Conjugates Targeting Integrin α(V)β(3)
por: Raposo Moreira Dias, André, et al.
Publicado: (2019)